WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 1 fonti

GLP-1s may raise risk for smell, taste disturbances in type 2 diabetes

Adults with type 2 diabetes may be more likely to report smell and taste disturbances if they were prescribed a GLP-1 receptor agonist, according to data published in JAMA Otolaryngology – Head & Neck Surgery. In an analysis of data from the TriNetX electronic health records database, researchers compared smell and taste disturbances among adults with type 2 diabetes who were prescribed a

Raccontata dahealio.com

Timeline cronologica

  1. martedì 14 luglio 2026·healio.com

    GLP-1s may raise risk for smell, taste disturbances in type 2 diabetes

    Adults with type 2 diabetes may be more likely to report smell and taste disturbances if they were prescribed a GLP-1 receptor agonist, according to data published in JAMA…

  2. martedì 14 luglio 2026·healio.com

    More studies tie GLP-1s to small risks for eye complications

    GLP-1 receptor agonists were associated with a higher risk for eye complications vs. other diabetes medications, two studies recently published in Annals of Internal Medicine…